Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets slip
Thu, 19 Jun 01:30 pm

After trading flat, Indian share markets fell in the negative territory in the post-noon trading session. Sectoral indices are trading mixed with oil and gas and metal stocks being the biggest losers whereas IT and auto stocks are leading the gains.

BSE-Sensex is down 94 points and NSE-Nifty is trading 31 points down. BSE Mid Cap is trading 0.4% down and BSE Small BSE Small Cap index is trading down by 0.2%. The rupee is trading at 59.91 to the US dollar.

Majority of the pharma stocks are trading in the red with Strides Acrolab and J B Chemicals being the biggest losers. However, Natco Pharma and Cadila Healthcare are among the few stocks trading in the green. As per a leading financial daily, Cipla has entered into an agreement with Hyderabad based company Hetero to launch a biosimilar version of Darbepoetin alfa. The product to be launched under the brand name 'Actorise' is indicated for the treatment of anaemia caused due to chronic kidney disease. The company had launched its first biosimilar product 'Etacept' last year in collaboration with a partner from China. Cipla's stock is currently trading down marginally.

Most of the auto stocks are trading in the green with Maharashtra Scooters and Tata Motors being among the major gainers. But Maruti Suzuki and Force Motors are among the few stocks trading in the red. As per a leading financial daily, Maruti Suzuki commissioned its 1 MW photovoltaic solar power plant at its Manesar facility. The facility has been built at a cost of Rs 103 m and will enable the company to offset 1,200 tonnes of carbon dioxide emissions every year. The power generated from the solar plant is synchronized with the natural gas-based captive power plant and will complement the power requirement in the facility. Maruti Suzuki's stock is currently trading down by 2.2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets slip". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.